New England Journal of Medicine: Osimertinib With or Without Chemotherapy in EGFR-Mutated Advanced NSCLC
New England Journal of Medicine: Combination Therapy for EGFR-Mutated Lung Cancer [editorial]
New England Journal of Medicine: Postmenopausal Osteoporosis
Lancet: Efficacy and Safety of Ligelizumab in Adults and Adolescents With Chronic Spontaneous Urticaria: Results of Two Phase 3 Randomised Controlled Trials
Lancet: Comparative Efficacy of Ligelizumab Versus Omalizumab in Chronic Spontaneous Urticaria [editorial]
Lancet: A New Age of Precision Gene Therapy
Journal of the Allergy and Clinical Immunology: Engineering Therapeutic Monoclonal Antibodies
Health Affairs: A Systematic Review of COVID-19 Misinformation Interventions: Lessons Learned
Health Affairs: Studies of Prescription Digital Therapeutics Often Lack Rigor and Inclusivity